VACCINEX INC (VCNX) Stock Analyst Earnings Estimates
NASDAQ:VCNX - Nasdaq - US9186403013 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 900K 44.00% | 275K -69.44% | 570K 107.27% | |
| EBITDA YoY % growth | -22.321M 20.35% | -19.699M 11.75% | -22.766M -15.57% | |
| EBIT YoY % growth | -22.49M 20.62% | -19.906M 11.49% | -22.885M -14.97% | |
| Operating Margin | -2,498.89% | -7,238.55% | -4,014.91% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -1.09 -890.91% | % | ||
| Q3 2022 Q2Q % growth | -0.11 35.29% | % | ||
| Q3 2021 Q2Q % growth | -0.17 99.82% | % | ||
| Q2 2021 Q2Q % growth | -44.10 46.15% | -62.12 | 18.02 | 29.01% |
| Q1 2021 Q2Q % growth | -0.26 99.72% | -0.38 | 0.12 | 31.11% |
| Q4 2020 Q2Q % growth | -60.48 24.21% | -80.33 | 19.85 | 24.71% |
| Q3 2020 Q2Q % growth | -92.40 21.43% | -93.18 | 0.78 | 0.83% |
| Q2 2020 Q2Q % growth | -81.90 49.35% | -109.24 | 27.34 | 25.03% |
| Q1 2020 Q2Q % growth | -94.50 43.04% | -160.65 | 66.15 | 41.18% |
| Q4 2019 Q2Q % growth | -79.80 | -124.24 | 44.44 | 35.77% |
| Q3 2019 Q2Q % growth | -117.60 | -141.37 | 23.77 | 16.82% |
| Q2 2019 Q2Q % growth | -161.70 | -149.94 | -11.76 | -7.84% |
| Q1 2019 Q2Q % growth | -165.90 | -159.94 | -5.96 | -3.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 52K 160.00% | % | ||
| Q1 2024 Q2Q % growth | 104K -81.09% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | 20K -60.00% | % | ||
| Q3 2022 Q2Q % growth | 50K | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | 50K -92.00% | % | ||
| Q3 2020 Q2Q % growth | 625K 54.70% | 625K | % | |
| Q2 2020 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q4 2019 Q2Q % growth | 51K | -51K | -100.00% | |
| Q3 2019 Q2Q % growth | 404K | 33.997K | 370.003K | 1,088.35% |
| Q2 2019 Q2Q % growth | 25K | 102K | -77K | -75.49% |
| Q1 2019 Q2Q % growth | 94K | 204K | -110K | -53.92% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |